It’s time to start thinking about seasonal vaccinations. Getting those annual jabs isn’t quite as simple as it was before the ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now expected to be down around ...

Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

We’ve taken a look at what a vaccine actually is and how long it might take until we get one, and news outlets have been reporting on the progress research teams around the world are making.

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2024. REUTERS/Brendan McDermid/File Photo The Nasdaq ended higher on Friday, driven by megacap ...